FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223414621> ?p ?o ?g. }

• W4223414621 endingPage "2933" @default.
• W4223414621 startingPage "2923" @default.
• W4223414621 abstract "Host immunity plays an important role in tumor development and treatment. Tumor-infiltrating lymphocytes (TILs) have been proven to predict the efficacy of neoadjuvant therapy (NAT) in breast cancer (BC) patients, but their application is limited due to various reasons. This study aims to explore the relationship between peripheral blood lymphocytes (PBLs) subsets distribution and the efficacy of NAT.Between December 2017 and March 2021, a total of 116 BC patients appropriate for NAT in Sun Yat-Sen University cancer center were enrolled, pre-NAC baseline blood samples were taken for further flow cytometry analysis to quantitatively evaluate the PBLs subsets distribution, and corresponding clinical information including pathological complete response (pCR) rate of NAT response were recorded.Baseline CD3+ T cells(OR 1.11, 1.03-1.21, p = 0.011), CD8+ T cells (OR 1.09, 1.02-1.18, p = 0.015), and NK cells (OR 0.91, 0.83-0.98, p = 0.028) in PBLs subgroup distribution were independent predictors of pCR in BC patients receiving NAT, in which CD8+ T cells had the highest predictive ability (AUC = 0.76). Compared with some previous prediction indicators, its prediction ability has been improved to some extent.Peripheral baseline CD3+ T cells, CD8+ T cells, and NK cells were independent predictors of pCR in BC patients receiving NAT, in which CD8+ T cells had the highest predictive ability. Therefore, it can provide newly non-invasive, relatively accurate and easily accessible predictors for corresponding patients, and help clinicians better understand tumor immunity." @default.
• W4223414621 created "2022-04-14" @default.
• W4223414621 creator A5011715383 @default.
• W4223414621 creator A5014317895 @default.
• W4223414621 creator A5020899727 @default.
• W4223414621 creator A5021343060 @default.
• W4223414621 creator A5055076133 @default.
• W4223414621 creator A5074068504 @default.
• W4223414621 creator A5077068949 @default.
• W4223414621 creator A5082811889 @default.
• W4223414621 creator A5085993678 @default.
• W4223414621 creator A5086458232 @default.
• W4223414621 date "2022-04-11" @default.
• W4223414621 modified "2023-10-10" @default.
• W4223414621 title "Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer" @default.
• W4223414621 cites W1661544713 @default.
• W4223414621 cites W1966656255 @default.
• W4223414621 cites W1977035973 @default.
• W4223414621 cites W2045059595 @default.
• W4223414621 cites W2059220359 @default.
• W4223414621 cites W2075894019 @default.
• W4223414621 cites W2087179076 @default.
• W4223414621 cites W2120431466 @default.
• W4223414621 cites W2137935883 @default.
• W4223414621 cites W2141436376 @default.
• W4223414621 cites W2157058802 @default.
• W4223414621 cites W2178133357 @default.
• W4223414621 cites W2221588520 @default.
• W4223414621 cites W2316247073 @default.
• W4223414621 cites W2466558384 @default.
• W4223414621 cites W2627073392 @default.
• W4223414621 cites W2744617457 @default.
• W4223414621 cites W2771978163 @default.
• W4223414621 cites W2789026035 @default.
• W4223414621 cites W2909793574 @default.
• W4223414621 cites W2914757005 @default.
• W4223414621 cites W2984294128 @default.
• W4223414621 cites W3016998224 @default.
• W4223414621 cites W3018084241 @default.
• W4223414621 cites W3024558728 @default.
• W4223414621 cites W3077251618 @default.
• W4223414621 cites W3083005508 @default.
• W4223414621 cites W3087393791 @default.
• W4223414621 cites W3088588360 @default.
• W4223414621 cites W3098349851 @default.
• W4223414621 cites W3119005666 @default.
• W4223414621 cites W3183916035 @default.
• W4223414621 cites W4223414621 @default.
• W4223414621 doi "https://doi.org/10.1002/cam4.4666" @default.
• W4223414621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35411609" @default.
• W4223414621 hasPublicationYear "2022" @default.
• W4223414621 type Work @default.
• W4223414621 citedByCount "1" @default.
• W4223414621 countsByYear W42234146212022 @default.
• W4223414621 crossrefType "journal-article" @default.
• W4223414621 hasAuthorship W4223414621A5011715383 @default.
• W4223414621 hasAuthorship W4223414621A5014317895 @default.
• W4223414621 hasAuthorship W4223414621A5020899727 @default.
• W4223414621 hasAuthorship W4223414621A5021343060 @default.
• W4223414621 hasAuthorship W4223414621A5055076133 @default.
• W4223414621 hasAuthorship W4223414621A5074068504 @default.
• W4223414621 hasAuthorship W4223414621A5077068949 @default.
• W4223414621 hasAuthorship W4223414621A5082811889 @default.
• W4223414621 hasAuthorship W4223414621A5085993678 @default.
• W4223414621 hasAuthorship W4223414621A5086458232 @default.
• W4223414621 hasBestOaLocation W42234146212 @default.
• W4223414621 hasConcept C114684123 @default.
• W4223414621 hasConcept C121608353 @default.
• W4223414621 hasConcept C126322002 @default.
• W4223414621 hasConcept C143998085 @default.
• W4223414621 hasConcept C167672396 @default.
• W4223414621 hasConcept C182516595 @default.
• W4223414621 hasConcept C203014093 @default.
• W4223414621 hasConcept C2778326572 @default.
• W4223414621 hasConcept C3017910909 @default.
• W4223414621 hasConcept C31258907 @default.
• W4223414621 hasConcept C41008148 @default.
• W4223414621 hasConcept C530470458 @default.
• W4223414621 hasConcept C553184892 @default.
• W4223414621 hasConcept C71924100 @default.
• W4223414621 hasConcept C8891405 @default.
• W4223414621 hasConcept C90924648 @default.
• W4223414621 hasConceptScore W4223414621C114684123 @default.
• W4223414621 hasConceptScore W4223414621C121608353 @default.
• W4223414621 hasConceptScore W4223414621C126322002 @default.
• W4223414621 hasConceptScore W4223414621C143998085 @default.
• W4223414621 hasConceptScore W4223414621C167672396 @default.
• W4223414621 hasConceptScore W4223414621C182516595 @default.
• W4223414621 hasConceptScore W4223414621C203014093 @default.
• W4223414621 hasConceptScore W4223414621C2778326572 @default.
• W4223414621 hasConceptScore W4223414621C3017910909 @default.
• W4223414621 hasConceptScore W4223414621C31258907 @default.
• W4223414621 hasConceptScore W4223414621C41008148 @default.
• W4223414621 hasConceptScore W4223414621C530470458 @default.
• W4223414621 hasConceptScore W4223414621C553184892 @default.
• W4223414621 hasConceptScore W4223414621C71924100 @default.
• W4223414621 hasConceptScore W4223414621C8891405 @default.
• W4223414621 hasConceptScore W4223414621C90924648 @default.

• next